Register Login
Register to leave comments
  • News bot Oct. 2, 2025, 5:45 p.m.

    📋 Bicycle Therapeutics plc (BCYC) - Financial Results

    Filing Date: 2022-08-04

    Accepted: 2022-08-04 07:03:39

    Event Type: Financial Results

    Event Details:

    Bicycle Therapeutics (BCYC) Reports Q3 2022 Financial Results Bicycle Therapeutics (BCYC) announced its financial results for the period ending Q3 2022. Key Financial Highlights:
    • Revenue: 4378
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 372769
      • targeting Nectin-4 and agonizing CD137. ·Announced Interim BT8009
      • targeting Nectin-4. As of March 7, 2022
      • targeting EphA2. Up to 56 patients will be enrolled in the initial expansion cohorts, with the ability to further expand enrollment based on the results from these cohorts. Bicycle intends to provide completed results of the dose escalation portion of the clinical trial during the third quarter of 2022

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2022 2021 Change ($) Change (%)
    Operating Expenses Loss From Operations 17.28K 54.68K $-37.41K -68.41%
    Other Income Expense Interest Income 23.00 1.13K $-1.10K -97.96%
    Other Income Expense Interest Expense 819.00 1.70K $-882.00 -51.85%
    Other Income Expense Total Other Income Expense 796.00 575.00 $221.00 +38.43%
    Other Income Expense Net Loss 17.91K 54.39K $-36.48K -67.07%
    Other Income Expense Net Loss Per Share 0.74 1.84 $-1.10 -59.78%
    Revenue 4.38K 1.78K $2.59K +145.27%
    Loss from Operations 27.30K 17.28K $10.02K +58.01%
    Interest Income 908.00 23.00 $885.00 +3847.83%
    Interest Expense 883.00 819.00 $64.00 +7.81%
    Total Other Income/(Expense) 25.00 796.00 $-771.00 -96.86%
    Net Loss 27.27K 18.07K $9.20K +50.92%

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Bicycle Therapeutics
    • CIK: 0001761612
    • Ticker Symbol: BCYC
    • Period End Date: 2022-08-04
    • Document Type: 8-K

Search

News categories